ArticleRSC advances2023
Flexible doctor blade-coated abiotic cathodes for implantable glucose/oxygen biofuel cells.
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Review on Catalytic Nanostructured Electrodes for Wearable and Implantable Abiotic Glucose Fuel Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Lignocellulosic Films: Preparation, Properties, and Applications.Chemical reviews · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Implantable devices powered by batteries have been used for sixty years. In recent devices, lithium-based batteries are the most widely used power source. However, lithium batteries have many disadvantages in terms of safety, reliability, and longevity and require regular monitoring and substitution. Implantable glucose biofuel cells (BFCs) are increasingly seen as a potential future technology for replacing lithium-based batteries because they do not require surgical replacement after 8-10 years and have a theoretically unlimited lifetime thanks to the continued recovery of glucose and oxygen present in the human body. This paper shows the fabrication of flexible implantable abiotic cathodes, based on a nitrogen/iron-doped graphene catalyst, for glucose/oxygen biofuel cell application. An ink, based on nitrogen-iron doped graphene as the abiotic catalyst and chitosan as a binder, was prepared and coated on a flexible teflonated gas diffusion layer using doctor blade coating. The characterization of the biocathode shows an open potential circuit corresponding to the potential of the abiotic catalyst and a high oxygen reduction current density of up to 66 μA cm
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.